Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Return on Invested Capital (2023 - 2025)

TriSalus Life Sciences (TLSI) has 3 years of Return on Invested Capital data on record, last reported at 1.94% in Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 2626.0% year-over-year to 1.94%; the TTM value through Dec 2025 reached 1.94%, down 2626.0%, while the annual FY2025 figure was 1.43%, 91.0% down from the prior year.
  • Return on Invested Capital reached 1.94% in Q4 2025 per TLSI's latest filing, up from 3.31% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 31.35% in Q3 2024 and bottomed at 6.09% in Q2 2025.
  • Average Return on Invested Capital over 3 years is 6.63%, with a median of 1.94% recorded in 2025.
  • Peak YoY movement for Return on Invested Capital: surged 3077bps in 2024, then tumbled -3466bps in 2025.
  • A 3-year view of Return on Invested Capital shows it stood at 5.81% in 2023, then surged by 385bps to 28.19% in 2024, then tumbled by -93bps to 1.94% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Invested Capital were 1.94% in Q4 2025, 3.31% in Q3 2025, and 6.09% in Q2 2025.